Table 1.
Participant | Phenotype | SNP | PolyPhena / SIFTb | Genotype | Ethnicity | Fasting glucose (mmol/l) |
Fasting insulin (pmol/l) |
BMI (kg/m2) |
---|---|---|---|---|---|---|---|---|
SIR1 | SIR, pseudoacromegaly |
c.233G>A p.S78N |
Benign / Tolerated | GA | Asian | 5.6 | 212 | 44.6 |
SIR2 | SIR, pseudoacromegaly |
c.1498C>G p.L500V |
Benign / Tolerated | CG | Asian | 6.0 | 264 | 39.7 |
SIR3 | SIR short stature |
c.1570A>G p.I524V |
Benign / Affect protein function |
AG | Turkish | 4.9 | 1358 | 19 |
SIR4 | SIR, pseudoacromegaly |
c.2485C>T p.P829S |
Benign / Tolerated | CT | Ashkena zy |
5.1 | 507 | 25.5 |
SIR5 | SIR | c.2566G>A p.A856T |
Benign / Tolerated | GA | Europid | 4.7 | 333 | 28 |
SIR6 | SIR FPLD1 |
c.2834C>T p.S945F |
Benign / Affect protein function |
CT | Europid | 5.5 | 155 | obese |
SIR7 | SIR, pseudoacromegaly |
c.3424G>C p.G1142R |
Possibly damaging / Affect protein function |
GC | Europid | 8.5 | 880 | 47.3 |
SIR8 | SIR, pseudoacromegaly |
c.3983A>G p.H1328R |
Possibly damaging / Affect protein function |
AG | Europid | 6.8 | 246 | 37.3 |
Control 1 | Healthy volunteer | c.1379C>T p.P460L and c.3983A>G p.H1328R |
Benign / Possibly damaging |
CT | Europid | 5.5 | 47 | 24.6 |
Control 2 | Healthy volunteer | c.3400A>G p.K1134E |
Benign / Affect protein function |
AG | Europid | 5.1 | 65 | 31.7 |
Control 3 | Healthy volunteer | c.3788G>T p.G1263V |
Probably damaging / Affect protein function |
GT | Europid | 6.4 | 43 | 24.3 |
Control 4 | Healthy volunteer | c.3983A>G p.H1328R |
Possibly damaging / Affect protein function |
AG | Europid | 4.9 | 45 | 23.4 |
PolyPhen predicts the possible impact of an amino acid substitution on the structure and function of a protein based on physical and comparative considerations
SIFT predicts whether an amino acid substitution affects protein function based on sequence homology and the physical properties of amino acids
FPLD1, familial partial lipodystrophy type 1, Online Mendelian Inheritance in Man (OMIM) (http://www.ncbi.nlm.nih.gov/omim) database ID: 608600; IR, insulin resistance